The ability of nuclear receptors (NRs) to mediate repression of positively regulated target genes depends largely on their association with corepressors such as SMRT and NCoR ([@r1][@r2][@r3]--[@r4]). In the classic model, corepressors bind to NRs in the absence of cognate ligands and dissociate from them upon ligand binding ([@r5][@r6]--[@r7]) providing a regulated "on-off" switch. NR signaling has been demonstrated to be critical during mouse development by numerous receptor knockout models and agonist treatments. Nonetheless, the contribution from corepressor-associated signaling has been unclear at best. Among NRs, two receptor families, retinoic acid receptors (RARs) and thyroid hormone receptors (TRs) stand out in terms of strong ligand-independent corepressor binding affinities and clear roles in vertebrate development.

During vertebrate development, retinoic acid (RA) plays critical roles in hindbrain and mesoderm segmentation ([@r6], [@r8][@r9]--[@r10]). Spatially complex expression of RA synthesis (Aldh1a2) and degradation (Cyp26) enzymes produces a RA gradient whose distinct thresholds along the axis have been demonstrated as critical events in rhombomere specification ([@r11]). In addition to the RA gradient, mutually inhibitory FGF/Wnt signaling has been shown to form an opposing gradient during somitogenesis ([@r12]). During this developmental window, segmental identity is conferred to newly formed somites at the "determination front" of caudal presomitic mesoderm, and once acquired, this positional information is maintained throughout axis elongation ([@r13]). This segmental identity is thought to be encoded by a combination of *Hox* gene expression pattern, known as the Hox code. During somitogenesis, *Hox* genes are directionally activated in a specific temporal sequence. This temporal colinearity has been closely associated with dynamic progression of chromatin modifications by increasing activation marks in conjunction with decreasing repressive marks ([@r14]). While RAR is known to directly regulate Hox promoters, the mechanism producing its spatially graded transcription is poorly understood ([@r15]). Here, we show that SMRT-dependent repression is a key determinant of the Hox code specification and maintenance by a direct effect on RA degradation and transcriptional repression of RAR target *Hox* genes.

The crucial role of RARs in neural crest cell (NCC)-derived craniofacial structures has long been established by genetic and pharmacological studies ([@r16]), yet the contributions of RAR-directed repression versus activation to this developmental process are unknown. Compound deletion of RAR α and β does not affect the early stages of NCC development up to embryonic day 10.5 (E10.5) ([@r16]). Nonetheless, the presence of misshapen bones in NCC-derived structures illustrates the importance of RAR-directed signaling in NCCs during late developmental processes, such as the modeling of skeletal elements ([@r17]). However, a previously insurmountable difficulty in studying the role of repression in RA-dependent pattern formation has been that the complete SMRT knockout is embryonic lethal, in part due to its association with numerous transcription factors, including p53, Myc, MyoD, PLZF, RelA/p65, and Stat5 ([@r18], [@r19]).

Previously, it has been demonstrated in mouse ES cells that RA also rapidly recruits super elongation complex (SEC) components to nonpaused target genes such as RA-degrading enzyme, *Cyp26a1* ([@r20]). This class of genes is unique in comparison with the RA-induced Hox gene clusters which possess paused-Pol II near their transcription start sites. Currently, it is unknown how these SEC components are rapidly recruited and regulated ([@r20]).

In the present study, by combining molecular, cellular, and gene targeting approaches, we demonstrated that the corepressor SMRT interactions with RARs are critical for specification and maintenance of axial Hox codes. We also show that repressive histone acetylation and methylation marks in Hox loci are established by histone deacetylases (HDACs) and Polycomb repressive complex (PRC) that are recruited by SMRT. Finally, we show that RA availability during development is regulated by SMRT-dependent transcriptional repression of the RA-degrading enzyme, *Cyp26a1*. These findings highlight unexpected roles for corepressor SMRT and importance of NR-dependent repression in murine axial development.

Results {#s1}
=======

SMRT^mRID^ Mutant Mouse Phenotype. {#s2}
----------------------------------

Importantly, newborn SMRT^mRID^ mice are born at expected Mendelian ratios and appear grossly normal except for a kinked tail, potential neural tube closure defect, as well as a 10% reduction in body size and weight ([*SI Appendix*, Fig. S1 *A* and *B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). This smaller body size and weight reduction persist until weaning. Postnatal metabolic phenotypes of SMRT^mRID^ mice have been discussed ([@r21]).

Normal Hindbrain Segmentation and Defective Cranial Neural Crest-Derived Structures. {#s3}
------------------------------------------------------------------------------------

In contrast to reported RAR-mediated forebrain and neural stem cell phenotypes of SMRT null mice ([@r19]), we did not observe any major defects in the SMRT^mRID^ cortex ([@r21]). As RAR signaling plays critical roles in hindbrain patterning ([@r16]), we examined rhombomere segmentation in E8.5--10.5 SMRT^mRID^ embryos ([*SI Appendix*, Fig. S1 *C* and *D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Although we did not observe abnormal expression of rhombomere marker genes during hindbrain segmentation in SMRT^mRID^ animals, 2 of 10 embryos exhibited fused branches of the 9th and 10th cranial ganglia ([*SI Appendix*, Fig. S1*E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Furthermore, we observed malformations in the retrotympanic processes of the squamous temporal bone and thyroid cartilage with 100% penetrance ([*SI Appendix*, Fig. S1 *F* and *G*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Interestingly, the spinous processes of the first and second cervical vertebrae were dramatically reduced in SMRT^mRID^ animals ([*SI Appendix*, Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). In addition, cervical spina bifida was prevalent in SMRT^mRID^ animals ([*SI Appendix*, Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). As these structures are formed by cells of cranial neural crest origin, we speculate that SMRT^mRID^ mice might suffer from NCC defects by either cell-autonomous or surrounding mesodermal RAR derepression ([@r22]). Together, these findings demonstrate that NR-dependent SMRT-directed repression is critical for the normal formation of NCC-derived skeletal elements rather than forebrain and neural progenitor developments as in whole-body SMRT null animals ([@r19]). Interestingly, the malformation of NCC-derived structures seen in SMRT^mRID^ mice was highly reminiscent of findings in Rara^NCC−/−^ mutants, suggesting that a SMRT/RAR pathway may direct other developmental programs ([@r17]).

Homeotic Transformation of Axial Vertebrae. {#s4}
-------------------------------------------

Next, we examined the expression pattern of SMRT in developing mouse embryos. Using whole mount in situ hybridization (WISH), the expression of *SMRT* was ubiquitously detected in the developing somites, with highest signals occurring in the tail somites ([*SI Appendix*, Fig. S2*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). qPCR analyses of the somite regions confirmed the *SMRT* WISH results ([*SI Appendix*, Fig. S2*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). The expression of the related corepressor *NCoR* in the somites closely resembled the somitic expression pattern for SMRT at E10.5 ([*SI Appendix*, Fig. S2*D*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). These results suggested that SMRT and/or NCoR could play an important role in axial development.

An examination of embryos at multiple stages revealed a striking posterior homeotic transformation of C5--7 cervical vertebrae and anterior transformation of L1 lumbar vertebrae in SMRT^mRID^ mice, similar to those found in embryos exposed to a high dose of systemic RA at E10.5--11 ([Fig. 1 *A--C*](#fig01){ref-type="fig"}). Tuberculi anterior (TA) flanges, which should normally be unique to C6, appeared on both C5 and C6 vertebrae ([Fig. 1*B*](#fig01){ref-type="fig"}). In some cases, C6 lost the foramen transversarium (FT) which, in the upper six vertebrae, provides passage to a plexus of sympathetic nerves and vertebral blood vessels ([*SI Appendix*, Fig. S2*E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). In addition, we found the frequent formation of either one or two incomplete ribs on C7, which are fused to the first thoracic rib ([*SI Appendix*, Fig. S2 *F* and *G*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). In 18% of SMRT^mRID^ mutants, the first lumbar vertebra (L1) acquires a thoracic identity with acquisition of a supernumerary 14th rib ([Fig. 1*C*](#fig01){ref-type="fig"}). The aforementioned axial pattern is highly reminiscence of that observed in Cyp26a1 null mice ([@r23]). No significant defects in somite size or overall number were observed in SMRT^mRID^ embryos as shown by WISH with somite markers, *Myogenin* and *Uncx4.1* ([*SI Appendix*, Fig. S2*H*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)), indicating that the homeotic shifts are not due to the global defects in somitogenesis. The above findings indicate that SMRT/NR-directed repression is an integral component in axial somite specification and that this repression cannot be compensated by another NR corepressor, NCoR.

![Axial homeotic transformation, its rescue by retinoid antagonist, and enhanced sensitivity to RA-induced abnormality in SMRT^mRID^. (*A*) Schematic diagram of axial transformations in SMRT^mRID^. Vertebrae are depicted as ovals. Yellow ovals with vv indicate presence of tuberculi anterior. Location of the 14th rib in SMRT^mRID^ is indicated in red. (*B*) Posterior transformation in cervical vertebrae of SMRT^mRID^. Filled circles and blue arrows indicate position of tuberculum anterior (TA). Incomplete rib anlages on C7 (54% of SMRT^mRID^) are indicated by black arrowheads. (*C*) Anterior transformation of lumbar vertebrae to thoracic. Presence of the 14th rib is indicated by arrowhead. (*D*) Rescue of cervical transformation in SMRT^mRID^ by RARα antagonist (BMS 204493) treatment at E10.5. WT and SMRT^mRID^ cervical columns are shown after antagonist treatment. (*E*) Typical cranial abnormality evident in SMRT^mRID^ after exogenous RA exposure at E10 with single dose of 100 mg/kg. Fusion between basioccipital (bo) and exoccipital (eo) bones in SMRT^mRID^ (white arrowheads). (*F*) Severe caudal truncations in SMRT^mRID^ after RA exposure as in *E*.](pnas.1809480115fig01){#fig01}

Rescue of Homeotic Transformation by RAR Antagonist at E10.5. {#s5}
-------------------------------------------------------------

These homeotic effects demonstrate that SMRT is a required mechanistic component to accurately translate the chemical RA agonist gradient into an appropriate somitic Hox code during somitogenesis. Indeed, the axial phenotype of SMRT^mRID^ mice is virtually identical to the previously described vertebral transformation seen with ectopic all-trans RA exposure, which is thought to disrupt axial positional information at late somitogenesis ([@r24]). This led us to wonder whether loss of repression in SMRT^mRID^ embryos could be rescued with a chemical retinoid antagonist such as BMS 493 (a pan-RAR antagonist). We chose the lower BMS 493 dose that is not teratogenic in wild-type (WT) embryos. Remarkably, this antagonist treatment at E10.5 led to a near complete reversal of posterior cervical transformations back into a WT pattern ([Fig. 1*D*](#fig01){ref-type="fig"} and [*SI Appendix*, Table S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)), indicating that a mechanism (chemical or genetic) to oppose RAR activation is critical for establishing or maintaining positional information. Together these results provide genetic evidence that somitic identity is dependent on genetic repression mediated by SMRT/RAR corepressor complexes during the E10.5--11 time window. Nonetheless, we could not rule out possible involvement of other corepressors such as NCoR or inhibition of coactivator recruitments upon RAR antagonist treatment. In addition, lack of phenotypic changes in WT control with BMS 493 treatment indicates that SMRT-dependent repression is required for stable RA-signaling gradient during late somitogenesis.

Furthermore, the above results suggest that SMRT^mRID^ mice may be generally more sensitive to exogenous RA exposure than wild-type littermates. While "standard" teratogenic doses of RA are 100 mg/kg ([Fig. 1 *E* and *F*](#fig01){ref-type="fig"}), in SMRT^mRID^ mice "nonteratogenic" doses of 5 mg/kg at E10.5 provoked cervical homeotic transformations ([*SI Appendix*, Table S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). This lack of protection against low-dose RA suggests that SMRT repression enhances the robustness of the gene expression gradient by shielding it from exposure to potential external perturbance such as fluctuations in RA concentrations ([*SI Appendix*, Table S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)) during late somitogenesis. This enhanced ability of RA to change somatic identities in already specified somites suggests that SMRT, as a platform for chromatin modifiers, could be required to maintain the chromatin modification status of relevant RAR targets such as *Hox* genes, at least for the duration of their patterning functions.

Shifted *Hox* Gene Expression Boundary in SMRT^mRID^ Mice. {#s6}
----------------------------------------------------------

Posterior cervical transformations are a classic example in which anterior expansion of *Hox* gene expression results in specification of anterior segments to more posterior ones ([@r25][@r26]--[@r27]). As retinoids are known to activate the *Hox* cluster, we assessed the expression boundaries of posterior *Hox* genes normally associated with cervical regions in SMRT^mRID^ embryos ([Fig. 2 *A* and *B*](#fig02){ref-type="fig"} and [*SI Appendix*, Fig. S3 *A* and *B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Interestingly, the increased expression of *Hoxc5* was detected in the anterior dorsal axis by qPCR ([Fig. 2*A*](#fig02){ref-type="fig"}). Notably, in situ hybridization assays confirmed that the anterior boundary of *Hoxc5* expression was shifted forward by one segment in SMRT^mRID^ embryos ([Fig. 2 *B--F*](#fig02){ref-type="fig"}). Additionally, after antagonist treatment at E10.5, the *Hoxc5* expression boundary was normalized to WT levels ([Fig. 2*G*](#fig02){ref-type="fig"}). This demonstrates that in addition to vertebral patterning, SMRT-dependent repression is required to maintain the Hox expression boundary for somite identity at late somitogenesis.

![Altered Hox expression domains in SMRT^mRID^. (*A*) Relative abundance of *Hoxc5* mRNA along the body axis at E11.5. A, B, and C denote the regions of the embryo depicted in *D*. The data are shown as the mean ± SEM. *n* = 5, \*\**P* \< 0.005 by Student's *t* test. (*B*) Whole mount in situ hybridization showing anterior expansion of *Hoxc5* expression boundary at E10.5. Somites are numbered from the forelimb level and arrow indicates the boundary of *Hoxc5* expression. (*C*) Section in situ of E10.5 axial somites. Note *Hoxc5* expression boundary is shifted to the seventh somite in comparison with WT embryos. (*D*) Anterior, A; middle, B; and caudal, C regions containing somites were used for mRNA quantitation. (*E*) Anterior expansion of *Hoxc5* expression boundary at E11.5. (*F*) Section in situ showing anterior expansion of *Hoxc5* expression domain in prevertebrae of E11.5 SMRT^mRID^ embryo. \* indicates anterior prevertebrae expressing *Hoxc5*. (*G*) Relative abundance of *Hoxc5* mRNA and in situ hybridization showing normalization of anterior *Hoxc5* expression boundary at E11.5 by RAR antagonist (BMS 493) treatment at E10.5. The data are shown as the mean ± SEM. *n* = 5.](pnas.1809480115fig02){#fig02}

Epigenetic Spatial Control of *Hox* Genes in SMRT^mRID^ Mice. {#s7}
-------------------------------------------------------------

SMRT has been identified as a component of histone deacetylase-containing protein complexes ([@r28], [@r29]). We wished to examine whether SMRT complexes play a role in the epigenetic control of *Hox* C loci in developing embryos at E10.5. We examined spatially distinct somite regions designated as front (F), middle (M), and rear (R) ([Fig. 3*B*](#fig03){ref-type="fig"} and [*SI Appendix*, Fig. S4*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)) in ChIP assays. In the mouse *Hox* C loci, RAREs are located both 3′ and 5′ to the *Hoxc4* locus. We first examined the occupancy of RAR and HDAC3, a component of SMRT complexes in the 5′ RARE ([Fig. 3*A*](#fig03){ref-type="fig"}). Occupancy of RAR was slightly reduced in all three somite regions of SMRT^mRID^ embryos. It has been suggested in prior ChIP studies that activation of RAR leads to reduction in its occupancy to its binding sites in certain target genes ([@r30], [@r31]). It is possible that SMRT derepression mimics receptor activation by decreasing RAR promoter occupancy. Occupancy of a SMRT complex component, HDAC3, was dramatically reduced in SMRT^mRID^ somites especially in M and R regions where most of the axial defects were identified. It is tempting to speculate that in the F region, other corepressors could compensate for SMRT in RAR-mediated repression as we did not find major defects in hindbrain specification.

![Epigenetic spatial control of Hox genes in SMRT^mRID^ mice. (*A*) Recruitment of RAR and HDAC3 to the *Hoxc4* RARE in three axial somites regions (F, front; M, middle; R, rear depicted in *B*). The data are shown as the mean + SEM. *n* ≥ 3. Locations of ChIP primer pairs are indicated as arrowheads in HoxC loci diagram. (*B*) Epigenetic histone modification status of *HoxC* loci in three axial somites regions (F, front; M, middle; R, rear depicted). The data are shown as the mean + SEM. *n* ≥ 3. (*C*) Recruitment of Jmjd3 and Suz12 containing PRC2 complex to *Hoxc5* exon 1 region in three axial somite regions (F, M, R, depicted in *B*). The data are shown as the mean + SEM. *n* ≥ 3. (*D*) *Hoxc5* derepression in PC19 EC cells by SMRT-C overexpression and 50 nM HDAC inhibitor, TSA. The data are shown as the mean + SEM. *n* = 5. (*E*) siRNA-mediated knockdown of *SMRT* or *Ezh2* expression resulted in *Hoxc5* derepression in P19 EC cells. The data are shown as the mean ± SEM. *n* = 5. ns, not statistically significant; \**P* \< 0.05; \*\**P* \< 0.005 by Student's *t* test.](pnas.1809480115fig03){#fig03}

Next, we looked at three chromatin marks (AcH3, H3K4me3, and H3K27me3) in exon 1 of each *Hox* C locus in spatially distinct somites of E10.5 embryos ([Fig. 3*B*](#fig03){ref-type="fig"}). Front somite regions (F), which are specified earlier than middle regions (M), had higher enrichments of AcH3 and H3K4me3 in the proximal *Hox* C loci. While H3K27me3 repressive marks were reduced in proximal *Hox* genes, they were increased in distal *Hox* C loci. Middle regions, which are specified earlier than rear regions (R) but later than front regions, displayed higher enrichment of activation marks in more distal *Hox* genes. At the same time, enrichment of repressive marks was not observed proximal to middle *Hox* genes. In distal *Hox* C-expressing rear regions, enrichment of repressive marks and absence of activation marks in proximal *Hox* were evident. Thus, spatial epigenetic marks closely resemble the known *Hox* C loci expression pattern along the rostral-to-caudal somites. Recently, it has been reported that NCoR occupancy was low to absent in *Hox* C loci during RA activation of ES cells ([@r32]). It is possible that *Hox* C loci are predominantly under the control of the SMRT/RAR complex.

As the SMRT^mRID^ mutation abrogates RAR-dependent recruitment of SMRT/HDAC corepressor complexes, we predicted an increase in histone acetylation of *Hox* C loci in SMRT^mRID^ embryos. Indeed, in SMRT^mRID^ somites, increased AcH3 marks were detected in certain *Hox* C loci in M and R regions ([Fig. 3*B*](#fig03){ref-type="fig"}). Unexpectedly, a reciprocal decrease in H3K27me3 marks was detected, a modification known to be mediated by Ezh2 methyltransferase as a part of the PRC2 complex ([@r33]). These repressive marks can be removed by opposing demethylases such as Jmjd3 and UTX ([@r34]). Therefore, we examined Jmjd3 and Suz12 (a PRC2 component) recruitment to the *Hoxc5* locus ([Fig. 3*C*](#fig03){ref-type="fig"}). Consistent with the reduced levels of H3K27me3, there was decreased occupancy of PRC2 methyltransferase complex (Suz12) only in SMRT^mRID^ somites, suggesting SMRT plays a role in maintaining the H3K27 trimethylation status of this Hox locus. There was a trend in increased occupancy of Jmj3 demethylase but did not reach statistical significance. Although, Jmjd3 has been suggested as a direct RAR target in neural stem cells, we did not detect derepression of *Jmjd3* expression in SMRT^mRID^ somites ([*SI Appendix*, Fig. S4 *B* and *C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)) ([@r19]).

We further examined the role of SMRT in *Hox* gene regulation in P19 embryonal carcinoma (EC) cells, a model system for RA-dependent activation of *Hox* genes ([Fig. 3*D*](#fig03){ref-type="fig"}). In transient transfection assays, overexpression of a SMRT^mRID^ construct did not change either basal or RA-dependent activation of endogenous *Hoxc5* expression, as expected from the lack of phenotype in heterozygous SMRT^mRID^ mice. In contrast, expression of a C-terminal portion of SMRT-containing RID but lacking repression domain (SMRT-C) resulted in derepression and enhanced RA-dependent activation of the *Hox* C5 locus, suggesting SMRT recruitment is required for repression of the *Hox* C5 locus ([Fig. 3*D*](#fig03){ref-type="fig"}). Knockdown of SMRT expression via siRNA also resulted in derepression and enhanced activation of *Hoxc5* genes ([Fig. 3*E*](#fig03){ref-type="fig"}). Furthermore, pharmacological inhibition of HDAC activity by trichostatin A (TSA) resulted in dramatic increase in *Hoxc5* expression, providing evidence for the importance of histone deacetylation in *Hoxc5* regulation. We further examined the role of H3K27 trimethylation in *Hoxc5* regulation by knocking down *Ezh2* methyltransferase by siRNA ([Fig. 3*E*](#fig03){ref-type="fig"}). Ezh2 knockdown resulted in derepression of *Hoxc5* similar to *SMRT* knockdown. Interestingly, *SMRT* knockdown or overexpression of SMRT-C in P19 EC cells resulted in increased expression of *NCoR* and *Ezh2*. *Ezh2* knockdown resulted in reciprocally enhanced expression of *SMRT* and *NCoR*, suggesting a dynamic link between SMRT and the polycomb repressive complex, PRC2 ([*SI Appendix*, Fig. S4 *D* and *E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). These results also implicate that SMRT is a preferential corepressor for RAR action in *Hox*c5 gene expression.

Enhanced RAR Activity and RA Clearance in SMRT^mRID^ Mice. {#s8}
----------------------------------------------------------

To further examine derepression of RAR in this mouse model, we crossed the SMRT^mRID^ mice with a transgenic reporter line (RARE-hsp-lacZ) in which in vivo activation of RAR can be visualized by β-galactosidase (β-gal) activity (SMRT^mRID^-RARE) ([@r35]). In SMRT^mRID^-RARE embryos, higher β-gal activity was present all along the dorsal axis as well as the otic and optic vesicles ([Fig. 4*A*](#fig04){ref-type="fig"}). Interestingly, the caudal boundary of reporter expression along the dorsal axis was unchanged relative to WT, suggesting that retinoic acid degrading activity is undiminished or potentially enhanced in the tailbud region of the presomitic mesoderm ([Fig. 4*B*](#fig04){ref-type="fig"}). Thus, despite presumptively increased RA signaling, a relatively normal embryonic development suggests that this process is not significantly perturbed in this region. This relatively undisturbed RARE-lacZ caudal boundary in the SMRT^mRID^ could be due to the higher expression of retinoid degrading activities.

![Derepression of RA-degradation enzyme *Cyp26a1* in SMRT^mRID^ and enhanced recruitment of SEC to its regulatory region. (*A*) Enhanced RAR-dependent β-galactosidase activity in SMRT^mRID^: RAREhsplacZ at E10.5. (*B*) Preserved caudal boundary of RAR transcriptional activity visualized by LacZ staining (blue). Somites from the tail to the boundary of LacZ signals are numbered. (*C* and *D*) Increased *Cyp26a1* expression in SMRT^mRID^ by in situ hybridization in *C* and qPCR in *D*. The data are shown as the mean ± SEM. *n* = 5. (*E* and *F*) Expression levels of *Cyp26b1* at E10.5 by in situ hybridization in *E* and qPCR in *F*. Arrows indicate sites of high *Cyp26* expression. The data are shown as the mean ± SEM. *n* = 5. (*G*) Embryonic tissue regions, A--C, used for mRNA quantitation by qPCR in *D* and *F*. (*H*) Increased mRNA RA-degradation enzyme *Cyp26a1* in the livers of 10-d-old and 2-mo-old SMRT^mRID^ mice. The data are shown as the mean ± SEM. *n* = 10. (*I*) Increased Cyp26a1 protein levels in liver of 2-mo-old SMRT^mRID^. (*J*) Temporal kinetics of RA-activated *Cyp26a1* mRNA in established WT and SMRT^mRID^ ES cells. SEC-recruited, not Pol II-paused genes including *Cyp26a1* are rapidly super induced by RA in SMRT^mRID^ ES cells. Time appears in hour scale. The data are shown as the mean ± SEM. *n* = 5. (*K*) Enhanced enrichment of SEC component AFF4 at *Cyp26a1* RARE in SMRT^mRID^ ES cells. The data are shown as the mean + SEM. *n* = 5. (*L*) Loss of SMRT/RAR association in mRID results in decreased threshold RA concentration for RAR target gene activation. (*M*) Model for SMRT as a genetic antagonist to RA-transcriptional gradient. SMRT also plays a role in retinoid homeostasis by repressing the RA-degradation pathway. Derepression of RAR targets such as Hoxc5 in cervical somites results in anterior expansion of the Hoxc5 boundary, ultimately resulting in posterior homeotic transformation of cervical vertebrae. Derepression of Cyp26a1 counteracts to increased RA-transcriptional activity by degrading RA in SMRT^mRID^. \**P* \< 0.05; \*\**P* \< 0.005 by Student's *t* test.](pnas.1809480115fig04){#fig04}

To the extent that a gene expression boundary is generated by the balance of a source and a sink ([@r36]), we wished to explore the impact of SMRT^mRID^ on potential changes in RA synthetic and metabolizing enzymes. qPCR analysis revealed that the expression of the critical RA-generating enzyme, *Aldh1a2*, was unchanged in SMRT^mRID^ embryos ([*SI Appendix*, Fig. S4*F*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)) ([@r37]). In contrast, analysis of the *Cyp26* genes encoding the RA-degrading enzymes ([@r23]) in the isolated somites revealed enhanced *Cyp26a1* expression in E10.5 SMRT^mRID^ embryos ([Fig. 4 *C--E*](#fig04){ref-type="fig"}). *Cyp26a1* is known to control RA-mediated signaling by limiting RA levels in a spatiotemporal manner ([@r38]). *Cyp26a1* deregulation was confirmed by WISH at different developmental stages ([Fig. 4 *C* and *E*](#fig04){ref-type="fig"} and [*SI Appendix*, Fig. S4 *G* and *H*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)) and suggests that SMRT-dependent repression is required for normal RA metabolism. The enhanced expression of *Cyp26a1* would result in more rapid degradation of RA and partially limit the teratogenic impact of derepressed RAR activity. Despite this compensatory RA clearance, the developmental phenotypes in SMRT^mRID^ clearly implicate that SMRT/RAR-dependent repression is a major player in RAR signaling. Since the robustness of the RA gradient heavily relies on the auto-induced ligand degradation ([@r39]), the inability to precisely compensate for the derepressed RAR activity in SMRT^mRID^ mice results in expanded *Hox* gene expression and aberrant specification of somitic identity.

*Cyp26a1* derepression persists postnatally as indicated by the dramatic sevenfold increase in the livers of 10-d-old and 2-mo-old SMRT^mRID^ mice ([Fig. 4 *H* and *I*](#fig04){ref-type="fig"}). To confirm that SMRT-dependent repression is a critical factor in *Cyp26a1* regulation, we examined the SMRT occupancy and acetylation status of *Cyp26a1* promoters in both WT and SMRT^mRID^ livers under vitamin A deficiency ([*SI Appendix*, Fig. S4*I*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). In vitamin A-deficient WT livers, SMRT is enriched on the *Cyp26a1* RARE while SMRT occupancy is compromised in SMRT^mRID^ livers, suggesting that *Cyp26a1* is a target of SMRT-dependent repression. Accordingly, in mutant mice, loss of SMRT recruitment to the *Cyp26a1* RARE results in increased acetylated histone marks and strongly suggests that SMRT helps to prevent excessive retinoid metabolism, which in nutrient-deficient environments is potentially life sparing.

Rapidly Induced RA Targets and Super Elongation Complex Recruitment in SMRT^mRID^ ES Cells. {#s9}
-------------------------------------------------------------------------------------------

SMRT has been identified as a cofactor that affects transcriptional initiation of NR target genes by recruiting corepressor complexes. Previously, A.S. and coworkers found that RA-induced targets in ES cells are also under the control of the SEC complex ([@r20]). Many of developmentally regulated genes such as Hox clusters are Pol II paused and ready to be activated by RA ([@r20]). As SMRT is a strong RAR protein interactor, we do observe derepression of RAR-regulated developmental target genes in SMRT^mRID^ animals. We wanted to know whether the derepression seen in SMRT^mRID^ embryos is also associated with the SEC complex in SMRT^mRID^ ES cells.

In SMRT^mRID^ ES cells, RA induction rapidly induces RAR-regulated *Hox* genes as early as 3 h posttreatment in comparison with WT ES cells ([*SI Appendix*, Fig. S5*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Interestingly, the *Hoxc5* gene was dramatically induced in SMRT^mRID^, strongly supporting our derepression view on posterior homeotic transformation and boundary shifting ([*SI Appendix*, Fig. S5*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Another notable difference is with *Cyp26a1* mRNA induction ([Fig. 4*J*](#fig04){ref-type="fig"}). This gene has been shown to be non-Pol II paused, but rapidly induced by RA with rapid RA-dependent recruitment of SEC complex ([@r20]). To see whether SEC recruitment is altered in SMRT^mRID^ ES cells, we performed a ChIP assay. At the *Cyp26a1* transcriptional start site, SEC components AFF4 and Pol II were detected after the RA treatment but greater enrichment was observed in SMRT^mRID^ compared with WT ([Fig. 4*K*](#fig04){ref-type="fig"}). The *Cyp26a1* locus has been shown to still retain repressive histone codes while it is induced by RA ([@r20]). It is possible that in SMRT^mRID^ ES cells, the recruitment of SEC by RA and decreased H3K27 trimethylation synergistically enhance its target expression ([Fig. 3*B*](#fig03){ref-type="fig"}). We also looked at the expression of RA-induced but SEC not-recruited genes and SEC-recruited Pol II-paused genes ([*SI Appendix*, Fig. S6*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental)). Expression of these genes was not consistently altered over the time course except for two *Hox* genes in SMRT^mRID^ ES cells, suggesting enhanced recruitment of SEC is only specific in certain classes of RA-controlled target genes. Furthermore, we found that SMRT is also important in regulation of the recruitment of SEC in non-Pol II paused, rapidly induced RA targets such as *Cyp26a1*.

Discussion {#s10}
==========

Our observations are summarized in the model shown in [Fig. 4 *L* and *M*](#fig04){ref-type="fig"}. While in WT animals, the SMRT complex is recruited to RAR/RXR target promoters in the absence of hormone, in SMRT^mRID^ mutants, derepression can enhance target gene activity in the absence of ligand and "superactivate" in the presence of ligand. Thus, loss of nuclear receptor-SMRT binding decouples the apo-receptor status and target silencing. While the depression affects many target genes at the transcriptional initiation steps, certain classes of genes are additionally derepressed at the elongation steps, such as *Cyp26a1*. These derepressions affect the Hox code expression and ultimately alter the somitic identity. Furthermore, we provide evidence that SMRT-dependent repression is critical for regulation of RA-metabolizing enzyme Cyp26a1 in both developing embryos and the postnatal liver.

Importantly, we demonstrated that SMRT has a nonredundant role with NCoR and that loss of SMRT interaction with nuclear receptors produces clear developmental phenotypes that can be rescued by the retinoid antagonist. Derepression in mutant mice sensitizes the RA-signaling axis, resulting in posterior homeotic transformation and enhanced teratogenic susceptibility to retinoic acid. This enhanced sensitivity to retinoid agonist and antagonist in already specified cervical somites at late somitogenesis in SMRT^mRID^ indicates that SMRT repression is critical for refining and maintaining the spatial boundaries in the developing somites until the formation of sclerotomes.

During somitogenesis, once Hox codes are established for newly formed somites, Hox expression domains must be maintained at least for the duration of their patterning period. To mediate the necessary long-term repression of *Hox* genes, components of PRC2 trimethylate H3K27. Mutations in Polycomb genes result in aberrant *Hox* gene expression, increased sensitivity to the teratogenic effect of RA, and posterior homeotic transformations similar to that observed in SMRT^mRID^ animals ([@r40]). The present study provides evidence that the SMRT corepressor complex is a critical component in the maintenance of this transcriptional cellular memory during late somitogenesis. Together these results lead us to propose that SMRT complex-dependent dynamic epigenetic antagonism is the mechanism through which the RA morphogenic field is translated to an epigenetic and gene expression gradient during murine axial development.

Methods {#s11}
=======

Animals. {#s12}
--------

SMRT^mRID^ knockin mice were generated by standard homologous recombination using an inserted *neo* cassette for positive selection and a *tk* cassette for negative selection. Chimeric mice were generated by microinjection of two independently targeted ES clones into blastocysts. Two independent mouse mutant lines were established. SMRT^mRID^ mice were backcrossed for at least four generations to sv129. Homozygous SMRT^mRID^ mice are viable in Sv129 or Sv129/C57BL6 mixed background, indicating that the previously described lethality of the SMRT^mRID^ is background specific ([@r41]). All mice were fed a Labdiet 5002 containing 18 IU/g vitamin A. All experiments involving mice were approved by the Committee on Animal Care at the Salk Institute for Biological Studies.

Further details on materials and methods used in skeletal preparations, in situ hybridization, transient transfection, siRNA-mediated knockdown, gene expression analysis, chromatin immunoprecipitation assays, pharmacological treatments, and vitamin A deficiency study are included in [*SI Appendix*, *Materials and Methods*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1809480115/-/DCSupplemental).
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